Abstract 【Objective】To explore the effect of ivabradine and Fuling Wenshen capsule in the treatment of patients with chronic heart failure. 【Methods】A total of 116 patients with chronic heart failure in our hospital from December 2018 to January 2021 were selected. According to the random number table method, they were divided into the observation group and the control group, with 58 cases in each group. On the basis of conventional treatment, the control group was treated with ivabradine for 4 weeks, and the observation group was treated with ivabradine combined with Fuling Wenshen capsule for 4 weeks. The clinical efficacy, adverse reactions, and Lee's heart failure scores before treatment, 2 weeks, and 4 weeks after treatment, Minnesota living with heart failure questionnaire (MLHFQ) score, 6-min walking distance (6MWT), cardiac function indexes [left ventricular ejection fraction (LVEF), cardiac output (CO), stroke volume (SV)], Bax and Caspase-3 protein expression were compared between the two groups. 【Results】After 4 weeks of treatment, the total effective rate in the observation group was 93.10% (54/58), which was lower than 79.31% (46/58) in the control group. The difference was statistically significant (χ2=4.64, P<0.05). Compared to before treatment, Lee's heart failure score and MLHFQ score of the two groups were significantly reduced after 4 weeks of treatment, and 6MWT was significantly increased. The improvement in the observation group was better than the control group; and the difference was statistically significant (P<0.05). After 4 weeks of treatment, the levels of LVEF, CO and SV in the two groups were significantly higher than those before treatment; And the observation group increased better than the control group, the difference was statistically significant (P<0.05). The expression of Bax and Caspase-3 in the two groups showed a decreasing trend if comparing to before treatment, and the observation group was lower than the control group (P<0.05). 【Conclusion】The combination of ivabradine and Fuling Wenshen capsule in the treatment of chronic heart failure has a significant clinical effect and good safety. It can effectively control the symptoms of heart failure in patients, improve exercise endurance and quality of life, and at the same time alleviate myocardial cell damage, reduce apoptosis, and improve cardiac function.
2021, Vol. 38 
